Matinas BioPharma Holdings MTNB
NYSE MTNB
$1.13 -0.10 (-8.26%)
As of: Nov 11, 2026 · 11:38 AM EST

Matinas BioPharma Holdings (MTNB) Shares Outstanding (Diluted) (2013 - 2026)

Updated

Matinas BioPharma Holdings (MTNB) posted Shares Outstanding (Diluted) of 6.41 million for Q2 2026, up 25.9% from 5.09 million a year earlier and unchanged from the prior quarter.

Analysis

Matinas BioPharma Holdings (MTNB) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends

For FY2025, Matinas BioPharma Holdings' Shares Outstanding (Diluted) came in at 5.47 million, up 12.5% from FY2024.

  • Annual Shares Outstanding (Diluted) shows a three-year compound annual growth rate of -70.7% (FY2022 to FY2025).
  • In prior years, Matinas BioPharma Holdings' Shares Outstanding (Diluted) was 4.87 million in FY2024 (+12.0%), 4.35 million in FY2023 (-98.0%) and 216.81 million in FY2022.
  • Quarterly Shares Outstanding (Diluted) has run from a low of 4.35 million in Q3 2023 to a high of 217.26 million in Q2 2023 over five years.
  • On a year-over-year basis, Shares Outstanding (Diluted) has increased in each of the last eight quarters, with growth averaging 14.9% over the last eight quarters.
  • The strongest year-over-year quarter for Shares Outstanding (Diluted) in the past five years was Q2 2026, with growth of 25.9%; the weakest was Q1 2024, with a decline of 98.0%.
  • According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 6.41 million (Q1 2026), 5.47 million (Q4 2025) and 5.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Matinas BioPharma Holdings 508,224.03 -12.08 Mn - 427,079.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 427,079.00
Mar 31, 2026 427,079.00
Dec 31, 2025 364,942.00
Sep 30, 2025 362,389.00
Jun 30, 2025 339,132.00
Mar 31, 2025 339,132.00
Dec 31, 2024 324,389.00
Sep 30, 2024 335,855.00
Jun 30, 2024 332,468.00
Mar 31, 2024 289,811.00
Dec 31, 2023 289,686.00
Sep 30, 2023 289,686.00
Jun 30, 2023 14.48 Mn
Mar 31, 2023 14.48 Mn
Dec 31, 2022 14.45 Mn
Sep 30, 2022 14.46 Mn
Jun 30, 2022 14.46 Mn
Mar 31, 2022 14.44 Mn
Dec 31, 2021 14.01 Mn
Sep 30, 2021 14.35 Mn
API Access

Matinas BioPharma Holdings Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=MTNB&period=max&api_key=YOUR_API_KEY